# Vroom, Inc.: financial statements, quarterly

VRM · Nasdaq · CIK 1580864 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vrm.md) · [Financials](/companies/vrm/financials.md) · [Filings](/companies/vrm/filings.md) · [Insiders](/companies/vrm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/vrm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [196](/filings/0000950170-23-019675.md) | [225](/filings/0000950170-23-039852.md) | [236](/filings/0000950170-23-060258.md) | [236 d](/filings/0000950170-24-030760.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Cost of revenue | $m | [158](/filings/0000950170-23-019675.md) | [179](/filings/0000950170-23-039852.md) | [188](/filings/0000950170-23-060258.md) | [207 d](/filings/0000950170-24-030760.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | [38.8](/filings/0000950170-23-019675.md) | [46.0](/filings/0000950170-23-039852.md) | [48.1](/filings/0000950170-23-060258.md) | [29.0 d](/filings/0000950170-24-030760.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [96.5](/filings/0000950170-23-019675.md) | [87.0](/filings/0000950170-23-039852.md) | [79.6](/filings/0000950170-23-060258.md) | [(263) d](/filings/0000950170-24-125412.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(68.3)](/filings/0000950170-23-019675.md) | [(52.6)](/filings/0000950170-23-039852.md) | [(42.5)](/filings/0000950170-23-060258.md) | [163 d](/filings/0000950170-24-125412.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [7.4](/filings/0000950170-24-057968.md) | [9.6](/filings/0000950170-24-094039.md) | [12.1](/filings/0000950170-23-060258.md) | [14.5 d](/filings/0000950170-24-030760.md) | [14.3](/filings/0000950170-24-057968.md) | [15.0](/filings/0000950170-24-094039.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.1](/filings/0000950170-24-057968.md) | [0.3](/filings/0000950170-24-094039.md) | [0.1](/filings/0000950170-24-125412.md) | [0.2 d](/filings/0000950170-25-037265.md) | [0.4](/filings/0000950170-25-071481.md) | [(0.2)](/filings/0000950170-25-105110.md) | [0.1](/filings/0001193125-25-274273.md) | [0.5 d](/filings/0001193125-26-126253.md) | [0.1](/filings/0001193125-26-332834.md) | [0.1](/filings/0001193125-25-274273.md) | [0.2](/filings/0001193125-26-224748.md) | [(0.0)](/filings/0001193125-26-332834.md) |
| Net income | $m | [(74.7)](/filings/0000950170-24-125412.md) | [(66.0)](/filings/0000950170-24-125412.md) | [(82.7)](/filings/0000950170-24-125412.md) | [(141) d](/filings/0000950170-25-037265.md) | [(67.6)](/filings/0001193125-25-274273.md) | [(21.2)](/filings/0001193125-25-274273.md) | [(39.7)](/filings/0001193125-25-274273.md) | [(36.6) d](/filings/0001193125-26-126253.md) | [(8.5)](/filings/0001193125-26-332834.md) | [(26.8)](/filings/0001193125-25-274273.md) | [(19.1)](/filings/0001193125-26-332834.md) | [0.6](/filings/0001193125-26-332834.md) |
| Diluted EPS | $ per share | [(43.16)](/filings/0000950170-24-057968.md) | [(37.97)](/filings/0000950170-24-094039.md) | [(47.38)](/filings/0000950170-24-125412.md) | not reported | [(37.68)](/filings/0000950170-25-071481.md) | [(11.77)](/filings/0000950170-25-105110.md) | [(21.99)](/filings/0001193125-25-274273.md) | not reported | [(1.65)](/filings/0001193125-26-332834.md) | [(5.15)](/filings/0001193125-25-274273.md) | [(3.77)](/filings/0001193125-26-224748.md) | [(0.01)](/filings/0001193125-26-332834.md) |
| Basic EPS | $ per share | [(43.16)](/filings/0000950170-24-057968.md) | [(37.97)](/filings/0000950170-24-094039.md) | [(47.38)](/filings/0000950170-24-125412.md) | not reported | [(37.68)](/filings/0000950170-25-071481.md) | [(11.77)](/filings/0000950170-25-105110.md) | [(21.99)](/filings/0001193125-25-274273.md) | not reported | [(1.65)](/filings/0001193125-26-332834.md) | [(5.15)](/filings/0001193125-25-274273.md) | [(3.77)](/filings/0001193125-26-224748.md) | [(0.01)](/filings/0001193125-26-332834.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2024-02-29) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | period not labelled (2025-01-15) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [94.0](/filings/0000950170-24-030760.md) | [91.0](/filings/0000950170-24-057968.md) | [63.4](/filings/0000950170-24-094039.md) | [51.1](/filings/0000950170-24-125412.md) | [29.3](/filings/0001193125-26-126253.md) | [35.4](/filings/0001193125-26-332834.md) | [14.6](/filings/0000950170-25-071481.md) | [14.3](/filings/0000950170-25-105110.md) | [12.4](/filings/0001193125-25-274273.md) | [10.4](/filings/0001193125-26-332834.md) | [14.5](/filings/0001193125-26-224748.md) | [16.4](/filings/0001193125-26-332834.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | not reported | [1,222](/filings/0000950170-24-057968.md) | [1,181](/filings/0000950170-24-094039.md) | [1,124](/filings/0000950170-24-125412.md) | [1,067](/filings/0001193125-26-126253.md) | [956](/filings/0001193125-26-332834.md) | [990](/filings/0000950170-25-071481.md) | [980](/filings/0000950170-25-105110.md) | [949](/filings/0001193125-25-274273.md) | [937](/filings/0001193125-26-332834.md) | [938](/filings/0001193125-26-224748.md) | [941](/filings/0001193125-26-332834.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total liabilities | $m | not reported | [1,161](/filings/0000950170-24-057968.md) | [1,138](/filings/0000950170-24-094039.md) | [1,119](/filings/0000950170-24-125412.md) | [1,098](/filings/0001193125-26-126253.md) | [791](/filings/0001193125-26-332834.md) | [831](/filings/0000950170-25-071481.md) | [828](/filings/0000950170-25-105110.md) | [823](/filings/0001193125-25-274273.md) | [821](/filings/0001193125-26-332834.md) | [818](/filings/0001193125-26-224748.md) | [820](/filings/0001193125-26-332834.md) |
| Long-term debt | $m | not reported | [548](/filings/0000950170-24-057968.md) | [795](/filings/0000950170-24-094039.md) | [729](/filings/0000950170-24-125412.md) | [381](/filings/0001193125-26-126253.md) | [366](/filings/0001193125-26-332834.md) | [655](/filings/0000950170-25-071481.md) | [564](/filings/0000950170-25-105110.md) | [492](/filings/0001193125-25-274273.md) | [423](/filings/0001193125-26-332834.md) | [578](/filings/0001193125-26-224748.md) | [489](/filings/0001193125-26-332834.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | not reported | [61.5](/filings/0001193125-25-274273.md) | [43.1](/filings/0001193125-25-274273.md) | [4.7](/filings/0001193125-25-274273.md) | [(30.9)](/filings/0001193125-26-332834.md) | [164](/filings/0001193125-26-332834.md) | [159](/filings/0001193125-26-332834.md) | [152](/filings/0001193125-26-332834.md) | [127](/filings/0001193125-25-274273.md) | [117](/filings/0001193125-26-332834.md) | [98.4](/filings/0001193125-26-332834.md) | [99.8](/filings/0001193125-26-332834.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: not reported
- Total assets: us-gaap:Assets
- Current liabilities: not reported
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q4 FY2022 (2022-12-31) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [114 d](/filings/0000950170-23-060258.md) | [(86.0) d](/filings/0000950170-24-030760.md) | [(85.0)](/filings/0000950170-24-057968.md) | [(147) d](/filings/0000950170-24-094039.md) | [(194) d](/filings/0000950170-24-125412.md) | [(108) d](/filings/0000950170-25-037265.md) | [23.1](/filings/0000950170-25-071481.md) | [(66.3) d](/filings/0000950170-25-105110.md) | [(31.7) d](/filings/0001193125-25-274273.md) | [(22.1) d](/filings/0001193125-26-126253.md) | [18.4](/filings/0001193125-26-224748.md) | [18.6 d](/filings/0001193125-26-332834.md) |
| Capital expenditure | $m | [3.9 d](/filings/0000950170-23-060258.md) | [4.3 d](/filings/0000950170-24-030760.md) | [0.8](/filings/0000950170-24-057968.md) | [0.4 d](/filings/0000950170-24-094039.md) | [0.7 d](/filings/0000950170-24-125412.md) | [0.7 d](/filings/0000950170-25-037265.md) | [0.6](/filings/0000950170-25-071481.md) | [0.3 d](/filings/0000950170-25-105110.md) | [1.2 d](/filings/0001193125-25-274273.md) | [1.4 d](/filings/0001193125-26-126253.md) | [1.5](/filings/0001193125-26-224748.md) | [1.3 d](/filings/0001193125-26-332834.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [138](/filings/0000950170-23-039852.md) | [138](/filings/0000950170-23-060258.md) | [1.7](/filings/0000950170-24-057968.md) | [1.7](/filings/0000950170-24-094039.md) | [1.7](/filings/0000950170-24-125412.md) | [1.8](/filings/0000950170-25-071481.md) | [1.8](/filings/0000950170-25-105110.md) | [1.8](/filings/0001193125-25-274273.md) | [5.2](/filings/0001193125-26-332834.md) | [5.2](/filings/0001193125-25-274273.md) | [5.2](/filings/0001193125-26-224748.md) | [5.2](/filings/0001193125-26-332834.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 5,207,627 at 2026-05-12, from the cover of the [10-Q filed 2026-05-15](/filings/0001193125-26-224748.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.